CATALYST PHARMACEUTICALS, INC. (CPRX) › Shareholders' EquityCATALYST PHARMACEUTICALS, INC. (CPRX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2002: $44.9K2003: $362.6K2004: $117.6K2005: $446.5K2006: $19.85M2007: $16.32M2008: $10.56M2009: $7.62M2010: $5.52M2011: $3.76M2012: $14.62M2013: $21.39M2014: $35.24M2015: $55.48M2016: $39.31M2017: $80.96M2018: $50.78M2019: $87.63M2020: $169.60M2021: $206.83M2022: $300.42M2023: $387.88M2024: $727.63M2025: $954.27M$954.27M2002Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$954.27M+31.1%2024$727.63M+87.6%2023$387.88M+29.1%2022$300.42M+45.2%2021$206.83M+22.0%2020$169.60M+93.5%2019$87.63M+72.6%2018$50.78M-37.3%2017$80.96M+106.0%2016$39.31M-29.1%2015$55.48M+57.4%2014$35.24M+64.8%2013$21.39M+46.3%2012$14.62M+288.8%2011$3.76M-31.8%2010$5.52M-27.6%2009$7.62M-27.9%2008$10.56M-35.3%2007$16.32M-17.8%2006$19.85M+4345.3%2005$446.5K+279.7%2004$117.6K-67.6%2003$362.6K+707.7%2002$44.9K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share